Alonso-González R,
Pérez-Hernández A, Silvestre-Rangil J, Silvestre FJ. Cardiovascular disease
versus periodontal disease: chronic systemic infection as a link. J Clin Exp
Dent. 2011;3(5):e476-82
doi:10.4317/jced.3.e476
http://dx.doi.org/doi:10.4317/jced.3.e476
References
1. Meurman JH, Sanz M, Janket SJ.
Oral health, atherosclerosis, and cardiovascular disease. Crit Rev Oral Biol
Med. 2004; 15: 403-13.
http://dx.doi.org/10.1177/154411130401500606
2. Genco R, Offenbacher S, Beck J.
Periodontal disease and cardiovascular disease: Epidemiology and possible
mechanisms. J Am Dent Assoc. 2002; 133 Suppl: 14S-22S
PMid:12085720
3. Spahr A, Klein E, Khuseyinova N,
Boeckh C, Muche R, Kunze M, et al. Periodontal infections and coronary heart
disease: role of periodontal bacteria and importance of total pathogen burden
in the Coronary Event and Periodontal Disease (CORODONT) study. Arch Intern
Med. 2006; 166: 554-9.
http://dx.doi.org/10.1001/archinte.166.5.554
PMid:16534043
4. Pussinen PJ, Alfthan G, Rissanen
H, Reunanen A, Asikainen S, Knekt P. Antibodies to periodontal pathogens and
stroke risk. Stroke. 2004; 35: 2020-3.
http://dx.doi.org/10.1161/01.STR.0000136148.29490.fe
PMid:15232116
5. Pussinen PJ, Jousilahti P, Alfthan
G, Palosuo T, Asikainen S, Salomaa V. Antibodies to periodontal pathogens are
associated with coronary heart disease. Arterioscler Thromb Vasc Biol. 2003;
23: 1250-4.
http://dx.doi.org/10.1161/01.ATV.0000072969.71452.87
PMid:12714435
6. Pussinen PJ, Tuomisto K,
Jousilahti P, Havulinna AS, Sundvall J, Salomaa V. Endotoxemia, immune response
to periodontal pathogens, and systemic inflamation associate with incident
cardiovascular disease events. Arterioscler Thtromb Vasc Biol. 2007; 27:
1433-9.
http://dx.doi.org/10.1161/ATVBAHA.106.138743
PMid:17363692
7. Milioti N, Bermudez-Fajardo A,
Penichet ML, Oviedo-Orta E. Review article: antigen-induced immunomodulation in
the patogénesis of aterosclerosis. Clin Dev Inmunol. 2008; 2008: 723539.
8. Cavrini F, Sambri V, Moter A,
Servidio D, Marangoni A, Montebugnoli L, et al. Molecular detection of
Treponema denticola and Porphyromonas gingivalis in carotid and aortic
atheromatous plaques by FISH: report of two cases. J Med Microbiol. 2005; 54:
93-6.
http://dx.doi.org/10.1099/jmm.0.45845-0
PMid:15591262
9. Ishihara K, Nabuchi A, Ito R,
Miyachi K, Kuramitsu HK, Okuda K. Correlation between detection rates of
periodontopathic bacterial DNA in carotid coronary stenotic artery plaque and
in dental plaque samples. J Clin Microbiol. 2004; 42: 1313-5.
http://dx.doi.org/10.1128/JCM.42.3.1313-1315.2004
PMid:15004106
PMCid:356820
10. Brodala N, Merricks EP, Bellinger
DA, Damrongsri D, Offenbacher S, Beck J, et al. Porphyromonas gingivalis
bacteremia induces coronary and aortic atherosclerosis in normocholesterolemic
and hypercholesterolemic pigs.Arterioscler Thromb Vasc Biol. 2005; 25: 1446-51.
http://dx.doi.org/10.1161/01.ATV.0000167525.69400.9c
PMid:15845905
11. Roth GA, Aumayr K, Giacona MB,
Papapanou PN, Schmidt AM, Lalla E. Porphyromonas gingivalis infection and
prothrombotic effects in human aortic smooth muscle cells. Thromb Res. 2009;
123: 780-4.
http://dx.doi.org/10.1016/j.thromres.2008.07.008
PMid:18789816
PMCid:2684328
12. Ogawa T. Immunogiological
properties of chemically defined lipid A from lipopolisaccharide of
Porphiromonas (Bacteroides) gingivalis. Eur J Biochem. 1994; 219:737-42.
http://dx.doi.org/10.1111/j.1432-1033.1994.tb18552.x
PMid:8112323
13. Gibson FC, Hong C, Chou H, Yumoto
H, Chen J, Lien E, et al. Innate immune recognition of invasive bacteria
accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation.
2004; 109: 2801-6.
http://dx.doi.org/10.1161/01.CIR.0000129769.17895.F0
PMid:15123526
14. Lourbakos A, Yuan YP, Jenkins AL,
Travis J, Andrade-Gordon P, Santulli R, et al. Activation of protease-activated
receptors by gingipains fron Porphyromonas gingivalis leads to platelet
aggregation: a new trait in microbial pathogenicity. Blood. 2001; 97:3790-7.
http://dx.doi.org/10.1182/blood.V97.12.3790
PMid:11389018
15. Song H, Bélanger M, Whitlock J,
Kozarov E, Progulske-Fox A. Hemaglutinin B is involved in the adherence of
Porphyromonas gingivalis to human coronary artery endothelial cells. Infect
Immun. 2005; 73: 7267-3.
http://dx.doi.org/10.1128/IAI.73.11.7267-7273.2005
PMid:16239522
PMCid:1273858
16. Sakurai K, Wang D, Suzuki J,
Umeda M, Nagasawa T, Izumi Y, et al. High incidente of actinobacillus
actinomycetemcomitans infection in acute coronary syndrome. Int Heart J. 2007;
48: 663-75.
http://dx.doi.org/10.1536/ihj.48.663
PMid:18160759
17. Miyamoto T, Yumoto H, Takahashi
Y, Davey M, Gibson FC 3rd, Genco CA. Pathogen-accelerated atherosclerosis
occurs early after exposure and can be prevented via immunization. Infect
Immun. 2006; 74:1376-80.
http://dx.doi.org/10.1128/IAI.74.2.1376-1380.2006
PMid:16428788
PMCid:1360301
18. Chi H, Messas E, Levine RA,
Graves DT & Amar S. Interleukin-1 receptor signaling mediates
atherosclerosis associated with bacterial exposure and /or a high-fat diet in a
murine apolipoprotein E heterozygote model: pharmacotherapeutic implications.
Circulation. 2004; 110: 1678-85.
http://dx.doi.org/10.1161/01.CIR.0000142085.39015.31
PMid:15353494
19. Madan M, Bishayi B, Hoge M &
Amar S. Atheroprotective role of interleukin-6 in diet- and/or
pathogen-associated atherosclerosis using an ApoE heterozygote murine model.
Atherosclerosis. 2008; 197:504-14.
http://dx.doi.org/10.1016/j.atherosclerosis.2007.02.023
PMid:17412346
PMCid:2430020
20. Brodala N, Merricks EP, Bellinger
DA, Damrongsri D, Offenbacher S, Beck J, et al. Porphyromonas gingivalis
bacteremia Induces coronary and aortic atherosclerosis in normocholesterolemic
and hypercholesterolemic pigs. Arterioscler Thromb Vasc Biol. 2005; 25;
1446-51.
http://dx.doi.org/10.1161/01.ATV.0000167525.69400.9c
PMid:15845905
21. Li L, Messas E, Batista EL Jr,
Robert A. Porphyromonas gingivalis infection accelerates the progression of
aterosclerosis in a heterozygous apolipoprotein E- deficient murine model.
Circulation. 2002; 105: 861-7.
http://dx.doi.org/10.1161/hc0702.104178
PMid:11854128
22. Yamazaki K, Honda T, Domon H,
Okui T, Kajita K, Amanuma R, et al. Relationship of periodontal infection to
serum antibody levels to periodontopathic bacteria and inflammatory markers in
periodontitis patients with coronary heart disease. Clin Exp Immunol. 2007;
149: 445-52.
http://dx.doi.org/10.1111/j.1365-2249.2007.03450.x
23. Beck JD, Eke P, Heiss G, Madianos
P, Couper D, Lin D, Moss K, et al. Periodontal disease and coronary heart
disease: A reappraisal of the exposure.Circulation. 2005; 112: 19-24.
http://dx.doi.org/10.1161/CIRCULATIONAHA.104.511998
PMid:15983248
24. Pussinen PJ, Nyyssönen, Alfthan
G, Salonen R, Laukkanen JA, Salonen JT. Serum antibody levels to Actinobacillus
actinomycetemcomitans predict the risk for coronary heart disease.
Arterioescler Thromb Vasc Biol. 2005; 25: 833-8.
http://dx.doi.org/10.1161/01.ATV.0000157982.69663.59
PMid:15692101
25. Demmer RT, Papapanou PN, Jacobs
DR Jr, Desvarieux M. Evaluating clinical periodontal measures as surrogates for
bacterial exposure: the Oral Infections and Vascular Disease Epidemiology Study
(INVEST). BMC Med Res Methodol. 2010; 10:2.
http://dx.doi.org/10.1186/1471-2288-10-2
PMid:20056008
PMCid:2820485
26. Davé S, Van Dyke TE. The link
between periodontal disease and cardiovascular disease is probably
inflammation. Oral Dis. 2008; 14:95-101.
http://dx.doi.org/10.1111/j.1601-0825.2007.01438.x
PMid:18302669
27. Tonetti MS, D’Aiuto F, Nibali L,
Donald A, Storry C, Parkar M, et al. Treatment of periodontitis and endothelial
function. N Engl J Med. 2007; 356:911-20.
http://dx.doi.org/10.1056/NEJMoa063186
PMid:17329698
28. Matthews JB, Wright HJ, Roberts
A, Ling-Mountford N, Cooper PR, Chapple IL. Neutrophil hyper-responsiveness in
periodontitis. J Dent Res.2007; 86:718-22.
http://dx.doi.org/10.1177/154405910708600806
PMid:17652198